Sensus Healthcare Launches New Line of Laser Systems to Provide Patients with Full Spectrum of Clinical and Aesthetic Dermatological Solutions

Lasers Address Acne Lesion Correction, Hair Removal and Tattoo Removal, Among Other Applications BOCA RATON, Fla., March 5, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today that the Company has launched Sensus Laser Systems, […]

What Does Basal Cell Carcinoma Look Like?

Basal cell carcinoma is a form of skin cancer that grows on areas of skin that are exposed to a lot of sunlight and UV radiation. If you’ve found a suspicious-looking spot on your skin that you think might be basal cell carcinoma, it’s natural to feel worried and scared. This is why it’s important […]

NBNA – SRT-100, Game Changer for Keloid Treatment

Dr. Michael H. Gold, a previously featured physician in our Physician Spotlight, has been featured in the Fall 2017 issue of National Black Nurses Association News.  Read the article here. SRT-100, Game Changer for Keloid Treatment Treating keloids is very frustrating, not only for the patient suffering from them, but also for the health care […]

Sensus Healthcare Opens Tel Aviv Office to Expand Footprint in Israel, the Middle East & Europe

BOCA RATON, Fla., Feb. 7, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today that the Company is opening a new office in Tel Aviv to deepen its presence in Israel, the Middle East and […]

Sensus Healthcare Launches Collaboration with BirchBioMed to Treat and Prevent Scarring for Keloids Patients Around the World

BOCA RATON, Fla., Feb. 5, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today Sensus’ collaboration with BirchBioMed Inc., a biomedical company focused on anti-scarring drugs, to treat and prevent scarring more effectively for patients […]

Sensus Healthcare Reports Record Revenue for 2017 Fourth Quarter and Full Year

Ninth consecutive quarter of double-digit year-over-year revenue growth Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 1, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results for the three […]

When to Suggest SRT Therapy Over Mohs Surgery

For decades, Mohs surgery has been considered the “gold standard” for the treatment of basal cell carcinomas and squamous cell carcinomas, even for cases where cosmetically important features of the face like the eyes, nose, lips, ears, and scalp are the area being treated. As the incidence of basal cell carcinoma and squamous cell carcinoma […]

How to Perform a Skin Cancer Self-Exam

According to the Skin Cancer Foundation, adults should thoroughly examine their skin on a monthly basis for signs of skin cancer, as well as visit a dermatologist for an annual professional skin exam. If you’ve never conducted a skin cancer self-exam before, now is the best time to start. Here are some tips to help […]

Sensus Healthcare to Host Fourth Quarter and Fiscal Year 2017 Financial Results and Business Update Conference Call on February 1, 2018

BOCA RATON, Fla., Jan. 25, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management will hold a conference call on Thursday, February 1, 2018 at 4:30 p.m. ET to discuss the financial results for […]

Offer Skin Cancer Treatment Without Surgery

Treating Non-Melanoma Skin Cancers When a person discovers they have non-melanoma skin cancer such as basal cell carcinoma or squamous cell carcinoma, the first question they have is, “How can I treat this?” The current most popular method of treatment for non-melanoma skin cancers is Mohs surgery. It’s praised for its effectiveness in successfully treating […]

Frequently Asked Questions About Keloid Scars

What’s the difference between hypertrophic scars and keloid scars? Hypertrophic scars are thick, raised scars that develop in the area where the skin is injured. Scars are normal during the human body’s healing process, but a hypertrophic scar is the result of an abnormal response to skin injury. The body produces too much collagen, so […]

Physician Spotlight – January 2018

Michael H. Gold, M.D., FAAD Founder and Medical Director of Gold Skin Care Center, Advanced Aesthetics Medical Spa, The Laser & Rejuvenation Center, and Tennessee Clinical Research Center: Clinical Assistant Professor, Vanderbilt University School of Nursing, Nashville, TN. As a dermatologist, we are constantly faced with skin cancers and with keloids in our practices. We […]

Should I Get the SRT-100 for My Practice?

Superficial radiation therapy was first used to treat non-melanoma skin cancers, such as basal cell and squamous cell carcinomas, back in the 1970s. For the last few decades, the treatment method fell out of use due to a decline in available machinery. Now, the treatment is making a resurgence as our machine becomes more widespread. […]